1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. MONTE ROSA THERAPEUTICS INC
Monte Rosa Therapeutics Inc XNAS: GLUE

Monte Rosa Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer, Getting Expensive
about

Monte Rosa Therapeutics Inc is a biotechnology company that specializes in developing molecular glue degraders (MGDs), a class of small molecule drugs that leverage the body's natural protein destruction mechanisms to selectively degrade therapeutica...

Read More
14.36 0.04 (0.28%)
New 52W High today
1.7M
XNAS Volume

XNAS 14 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Monte Rosa Therapeutics Inc is on 18 Nov 2025 for the purpose of Jefferies Global Healthcare Conference in London See details
Durability score
High Financial Strength
61.1 / 100
Valuation Score
Mid Valuation
38.3 / 100
Momentum Score
Technically Bullish
79.3 / 100
Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM
Analyst Price Target
17
1Yr Price target upside is 20%
5 analysts

27

S

5

W

1

O

3

T

SWOT Analysis

Monte Rosa Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..